Peptides News and Research

RSS

Antimicrobial peptide packaged in silicon nanoparticle could combat drug-resistant bacteria

Antibiotic resistance is a growing problem, especially among a type of bacteria that are classified as "Gram-negative." These bacteria have two cell membranes, making it more difficult for drugs to penetrate and kill the cells.

13 Jul 2017

Ocular microbiome trains developing immune system to ward off pathogens, study shows

Bugs in your eyes may be a good thing. Resident microbes living on the eye are essential for immune responses that protect the eye from infection, new research shows.

11 Jul 2017

Synthetic compound that reads mitochondrial DNA could lead to treatments for nerve, muscle diseases

For the first time, a synthetic compound has been made that can bind to DNA in the cells' energy powerhouses, suppressing a gene associated with nerve and muscle disease.

11 Jul 2017

New technology could help patients requiring stem cell therapies for Parkinson's, stroke, other diseases

A groundbreaking advancement in materials from Northwestern University could potentially help patients requiring stem cell therapies for spinal cord injuries, stroke, Parkinson's disease, Alzheimer's disease, arthritic joints or any other condition requiring tissue regeneration, according to a new study.

10 Jul 2017

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

5 Jul 2017

Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins

The design of tailored peptide-polymer conjugates as drug-specific formulation additives offers access to next generation precision additives that can render problematic small organic drugs water-soluble and improve bioavailability.

30 Jun 2017

Dysfunctional microglia cells contribute to loss of synapses in Alzheimer's disease

Similar to other neurodegenerative disorders, Alzheimer's is a disease in which the cognitive abilities of afflicted persons continuously worsen.

30 Jun 2017

New lab-on-a chip predicts preterm birth risk

Preterm birth is the leading cause of neonatal morbidity and mortality. Among the many underlying causes of pregnancy-associated complications, it is known that infection and inflammation are highly significant risk factors.

29 Jun 2017

Scientists use supercomputers to test new techniques for early cancer detection

An important factor in fighting cancer is the speed at which the disease can be identified, diagnosed and treated.

28 Jun 2017

Researchers identify new therapy target for gonorrhea

Researchers have identified a possible new treatment for gonorrhea, using a peptide that thwarts the infection-causing bacterium by interfering with an enzyme the microbe needs to respirate.

27 Jun 2017

New monoclonal antibody shows efficacy in chronic migraine patients with medication overuse

A new human antibody may soon become available as a specific medication for preventing frequent migraine attacks.

27 Jun 2017

New algorithm shortens drug discovery times from years to months

An algorithm developed at the Hebrew University cuts through the immense number of possible solutions to shorten drug discovery times from years to months.

22 Jun 2017

Scientists design bioactive nanomaterial that excels at stimulating bone regeneration

There hasn't been a gold standard for how orthopaedic spine surgeons promote new bone growth in patients, but now Northwestern University scientists have designed a bioactive nanomaterial that is so good at stimulating bone regeneration it could become the method surgeons prefer.

19 Jun 2017

New tools can potentially play key role in early diagnosis of systemic sclerosis

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.

14 Jun 2017

Study shows how RNA splicing errors may trigger development of ALS, FTD

The most frequent genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)- rare and related neurological disorders marked by progressive deterioration of motor or cognitive abilities- may be due to errors in RNA splicing, an intermediary step for translating genetic instructions into functional proteins.

14 Jun 2017

Researchers use quantum dots to decipher design features for new therapies aimed at MS

Researchers in the University of Maryland Fischell Department of Bioengineering (BIOE) Jewell Laboratory are using quantum dots - tiny semiconductor particles commonly used in nanotechnology - to decipher the features needed to design specific and effective therapies for multiple sclerosis (MS) and other autoimmune diseases.

14 Jun 2017

Vitamin A improves insulin-producing beta-cells' function, study suggests

There has been no known link between diabetes and vitamin A - until now. A new study suggests that the vitamin improves the insulin producing β-cell´s function.

13 Jun 2017

Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patients

Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life.

13 Jun 2017

Roche to showcase new solutions for lab innovation at EuroMedLab

Roche announced today that it will be showcasing new solutions for lab innovation and leadership at the 22nd IFCC–EFLM European Congress of Clinical Chemistry and Laboratory Medicines in Athens, Greece, 11–15 June.

From Roche Sequencing and Life Science 13 Jun 2017

Southern Research aims to develop new radiosensitizers that may greatly benefit cancer patients

Two out of three cancer patients are treated with radiation, but the therapy often fails to wipe out the tumor or slow its growth. Southern Research is working to develop a new class of drugs that will help the radiation deliver a more powerful punch to the disease.

9 Jun 2017

Peptides News and Research

Antimicrobial peptide packaged in silicon nanoparticle could combat drug-resistant bacteria

Ocular microbiome trains developing immune system to ward off pathogens, study shows

Synthetic compound that reads mitochondrial DNA could lead to treatments for nerve, muscle diseases

New technology could help patients requiring stem cell therapies for Parkinson's, stroke, other diseases

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins

Dysfunctional microglia cells contribute to loss of synapses in Alzheimer's disease

New lab-on-a chip predicts preterm birth risk

Scientists use supercomputers to test new techniques for early cancer detection

Researchers identify new therapy target for gonorrhea

New monoclonal antibody shows efficacy in chronic migraine patients with medication overuse

New algorithm shortens drug discovery times from years to months

Scientists design bioactive nanomaterial that excels at stimulating bone regeneration

New tools can potentially play key role in early diagnosis of systemic sclerosis

Study shows how RNA splicing errors may trigger development of ALS, FTD

Researchers use quantum dots to decipher design features for new therapies aimed at MS

Vitamin A improves insulin-producing beta-cells' function, study suggests

Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patients

Roche to showcase new solutions for lab innovation at EuroMedLab

Southern Research aims to develop new radiosensitizers that may greatly benefit cancer patients

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News